Matricelf Ltd (TLV:MTLF)
Israel · Delayed Price · Currency is ILS · Price in ILA 471.20
-16.80 (-3.44%)
At close: Mar 13, 2026
Matricelf Market Cap
Matricelf has a market cap or net worth of 137.8 million as of March 13, 2026. Its market cap has increased by 138.76% in one year.
Market Cap
137.80M
Enterprise Value
133.54M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
471.20
Market Cap Chart
Since June 20, 2021, Matricelf's market cap has increased from 62.00M to 137.80M, an increase of 122.27%. That is a compound annual growth rate of 18.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 137.80M | -9.31% |
| Dec 31, 2025 | 151.94M | 156.50% |
| Dec 31, 2024 | 59.23M | 18.14% |
| Dec 31, 2023 | 50.14M | -7.15% |
| Dec 29, 2022 | 54.00M | -47.98% |
| Dec 30, 2021 | 103.80M | 67.43% |
| Jun 20, 2021 | 62.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 498.70M |
| Geffen Residence & Renewal | 263.65M |
| Clal Biotechnology Industries | 44.86M |
| BioLineRx | 39.16M |
| BioLight Life Sciences | 29.14M |
| Evogene | 22.34M |
| XTL Biopharmaceuticals | 19.87M |
| Purple Biotech | 18.58M |